Accepted Model for Brain Signaling Flawed Jan. 10, 2013

New Post Public Reply Private Reply Replies (0) Message Board
PoemStone

Accepted Model for Brain Signaling Flawed

Jan. 10, 2013 — A new study out January 10 in the journal Science turns two decades of understanding about how brain cells communicate on its head. The study demonstrates that the tripartite synapse -- a model long accepted by the scientific community and one in which multiple cells collaborate to move signals in the central nervous system -- does not exist in the adult brain.

A new study out January 10 in the journal Science turns two decades of understanding about how brain cells communicate on its head. The study demonstrates that the tripartite synapse -- a model long accepted by the scientific community and one in which multiple cells collaborate to move signals in the central nervous system -- does not exist in the adult brain.

"Our findings demonstrate that the tripartite synaptic model is incorrect," said Maiken Nedergaard, M.D., D.M.Sc., lead author of the study and co-director of the University of Rochester Medical Center (URMC) Center for Translational Neuromedicine. "This concept does not represent the process for transmitting signals between neurons in the brain beyond the developmental stage."

The central nervous system is home to many different cells. While neurons tend to garner the most attention, it is only recently that the function of the brain's other cells have been fully appreciated. Glial cells known as astrocytes, for example, had long been considered mainly the "glue" that helps hold all the other cells in the central nervous system in place. Scientists now understand that that these cells are essential to maintaining a healthy environment in the brain by helping carry out functions such as removing waste.

"Neurons are like a racing car," said Nedergaard. "While the driver gets all the credit, there are often 20 people behind the scenes that are optimizing his or her success."

However, when it comes to moving signals between neurons in the brain it turns out that the scientists may have vastly exaggerated the role of the astrocyte.

Neurons are connected to each other via axons or "arms" that extend from the cell's main body. Communication between neighboring neurons takes place where axons meet other nerve cells -- called a synaptic juncture -- when an electrical charge causes chemicals called neurotransmitters or glutamate to be released by one cell and "read" by receptors on the surface of the opposite. The two cells do not actually touch, so the chemicals messages must pass through a gap in the synaptic juncture. The space around this gap is insulated by astrocytes.

Under the tripartite synapse model, both astrocytes and neurons were believed to play a role in the "conversation" between cells. This understanding was largely based on animal models which showed active receptors and neurotransmission between not only the nerve cells but also the nearby astrocytes.

Specifically, a key neurotransmission receptor called metabotropic glutamate receptor 5 (mGluR5) was observed to be present and active in astrocytes at the synaptic juncture. It was also observed that when the mGluR5 receptor was activated, the astrocytes would release chemical transmitters that were in turn read by the nerve cells. These findings led to the conclusion that astrocytes must in some manner modulate the signaling process between brain cells.

While this model has held sway for decades, scientists have long been frustrated by their inability to influence this process by targeting it with drugs.

"If this concept was correct, it should have given rise to a clinical trial by now," said Nedergaard. "It has not, which tells us that with so many labs work on this for 20 years that there must be something wrong."

One of the barriers to understanding precise mechanics of passing signals from one neuron to another has been the inability to observe this process in the adult brain. The tripartite synapse model was based -- in part -- by examining the activity in the brains of very young rodents. Adult rodents could not be similarly studied because the synapses in the brain would die before they could be fully analyzed. This ultimately led to the presumption that the signaling process that was witnessed in the young brain carried over to adulthood.

Collaborating with researchers at the University of Rochester's Institute of Optics, Nedergaard and her team developed a new 2-photon microscope that enables researchers to observe glia activity in the living brain. Using both this method and by analyzing the gene and protein expression in the brain the researchers discovered that the mGluR5 largely disappear in the glial cells of adult mice meaning that these cells do not directly respond to synaptic neuronal signalling, thus calling into question the concepts that drive most of ongoing research in the field.

"The process of neuron-glial transmission as conceived by the tripartite synapse model appears to just be a simplistic signaling pathway that 'teaches' the synapse how to behave," said Nedergaard. "Once the brain matures, it goes away."

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Scroll down for more posts ▼

Top 10 Most Recent News Articles

The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing K-12 Education: Five Star's Virtual Help Desk

Updated Category News Views 159

Five Star Technology Solutions' Anniversary Celebration Five Star Technology Solutions proudly commemorates three years since the launch of its innovative Virtual Help Desk (vHD), a service dedicated to enhancing K–12 education. This powerful tool has redefined how schools and districts obtain technical support, resulting in increased efficiency and cost savings, while...

Continue Reading
Exploring the Dynamics of Small-Cap Investments in RVT

Updated Category News Views 181

Understanding Royce Small-Cap Trust Royce Small-Cap Trust (NYSE: RVT) stands as the oldest and largest closed-end fund dedicated to small-cap stocks. By focusing on these smaller companies, the trust has carved out a unique niche in the investment landscape. Key Highlights The fund enjoys an impressive weekly trading volume of around 974,286 shares, reflecting strong...

Continue Reading
Projected Growth of Peripheral Intravenous Catheters Market

Updated Category News Views 215

Overview of the Peripheral Intravenous Catheters Market The peripheral intravenous catheters (PIVCs) market is on track to reach a striking valuation of USD 10.9 billion by 2032. This expected growth is primarily propelled by the rising number of both elective and emergency surgeries conducted around the world. Increasing Need for Intravenous Access Every year, over 310...

Continue Reading
Vaxart Announces New Lead Independent Director Appointment

Updated Category News Views 122

Appointment of W. Mark Watson SOUTH SAN FRANCISCO, Calif. — Vaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company, proudly announces the appointment of W. Mark Watson as its Lead Independent Director. With a wealth of knowledge spanning over 50 years in the field of accounting and business, Mr. Watson is set to significantly enhance the strategic direction...

Continue Reading
Legal Review of Potential Securities Fraud by Stellantis N.V.

Updated Category News Views 176

Understanding the Investigation into Stellantis N.V. There is an ongoing investigation regarding potential securities fraud claims against Stellantis N.V. (NYSE: STLA). This inquiry arises due to allegations that the company may have made inaccurate statements about its business performance and future prospects. The focus of the investigation highlights key elements of...

Continue Reading